Salivary anti-SARS-CoV-2 IgA as an accessible biomarker of mucosal immunity against COVID-19

Abstract excerpt

<h4>Background</h4> Mucosal immunity, including secretory IgA (sIgA), plays an important role in early defenses against respiratory pathogens. Salivary testing, the most convenient way to measure sIgA, has been used to characterize mucosal immune responses to many viral infections including SARS, MERS, influenza, HIV, and RSV. However, its role has not yet been characterized in the COVID-19 pandemic. Here, we rep...

Topics

Open a Topic to create a Post that cites this publication.

• Advanced biosensing and bioanalysis techniques
• COVID-19 diagnosis using AI
• Gut microbiota and health
• Oral microbiology and periodontitis research
• Respiratory viral infections research
• Salivary Gland Disorders and Functions
• SARS-CoV-2 and COVID-19 Research
• SARS-CoV-2 detection and testing

Identifiers and source

Literature Corpus work

622d5d45-606f-5d8b-9464-6f69616bc9fc

DOI

10.1101/2020.08.07.20170258